![](/media/img/foto-membre-gran@2x.png)
Clàudia Fortuny Guasch
Investigador
Research group
Professional network profiles
Last Publications
- Gamell Fullà A, Velasco E, López-Ramos MG, Rios-Barnés M, Simó-Nebot S, Fumadó V, Noguera-Julián A and Fortuny-Guasch C Off-label use of dalbavancin in children: a case series JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . : .
- Agüera M, Soler-García a, Alejandre C, Moussalam-Merino S, Sala-Castellví P, Pons G, Penela-Sánchez D, González-Grado C, Alsina-Rosell J, Climent C, Esteva-Afonso C, Fortuny-Guasch C, Fernández de Sevilla-Estrach M, García-García JJ, Brotons-de los Reyes P, Balaguer A, Estrada J, Jordán-García I, Munoz-Almagro C and Launes-Montana C Nirsevimab immunization's real-world effectiveness in preventing severe bronchiolitis: A test-negative case-control study PEDIATRIC ALLERGY AND IMMUNOLOGY . 35(6): .
- Epalza, C, Valadés-Alcaraz, A, González-Alba, JM, Beltrán-Pavez, C, Gutiérrez-López, M, Rubio-Garrido, M, Fortuny-Guasch C, Frick, MA, Medina, LM, Moreno, S, Sanz, J, Rojo, P, Navarro, ML and Holguín, A Transmitted Drug Resistance and HIV Diversity Among Adolescents Newly Diagnosed With HIV in Spain PEDIATRIC INFECTIOUS DISEASE JOURNAL . 43(1): 40-48.
Projects
- Project name:
- SGR 2022-2024_Enfermedades Infecciosas en la Edad Pediátrica y Microbioma
- Leader
- Carmen Muñoz Almagro
- Funding entities:
- Agaur - Agència de Gestió d'Ajuts Universitaris i de Recerca
- Code
- 2021 SGR 00396
- Starting - finishing date:
- 2022 - 2025
- Project name:
- Science4Pandemics: Cizitens engagement digital platform for collective intelligence in pandemics
- Leader
- Begoña Nafria Escalera
- Funding entities:
- Fundació Privada per a la Recerca i la Docència Sant Joan de Déu - FSJD, EIT Health e.V
- Code
- 220365
- Starting - finishing date:
- 2022 - 2024
- Project name:
- Estudio de la toxicidad mitocondrial en recien nacidos y lactantes con infección congénita por citomegalovirus tratados con ganciclovir o valganciclovir
- Leader
- Clàudia Fortuny Guasch
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI17/00359
- Starting - finishing date:
- 2018 - 2022
News
-
Measuring antibodies in saliva is a useful and easy strategy to detect SARS-CoV-2 infections
A study, published in BMC Medicine, performed through the Kids Corona platform from Sant Joan de Déu in collaboration with ISGlobal, shows that measuring antibodies in saliva is a useful and easy strategy to detect SARS-CoV-2 infections.